You suggest Pfizer had a 100 billion reasons to do better studies. Some might argue they had 100 billion reasons to NOT do the studies. After all, RCTs showing a smaller effect (or even a net harm in some populations) may have made it harder to push and mandate these interventions the way they were.
You suggest Pfizer had a 100 billion reasons to do better studies. Some might argue they had 100 billion reasons to NOT do the studies. After all, RCTs showing a smaller effect (or even a net harm in some populations) may have made it harder to push and mandate these interventions the way they were.
You suggest Pfizer had a 100 billion reasons to do better studies. Some might argue they had 100 billion reasons to NOT do the studies. After all, RCTs showing a smaller effect (or even a net harm in some populations) may have made it harder to push and mandate these interventions the way they were.